You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

D0 Prostate Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Specific Antigens, Prostate Tumors Trial run by the National Cancer Institute (NCI) (TARP peptide vaccine, TARP

Completed
Has Results
  • Prostate Specific Antigens
  • Prostate Neoplasms
  • T-cell receptor alternate reading frame protein (TARP) peptide vaccine
  • T-cell receptor alternate reading frame protein (TARP) dendritic cell vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 15, 2022

Prostatic Tumors, Prostate Cancer Trial run by the NCI (Autologus elutriated monocyte vaccine, Multi-epitope (ME) T-cell

Terminated
Has Results
  • Prostatic Neoplasms
  • Prostate Cancer
  • Autologus elutriated monocyte placebo vaccine
  • Multi-epitope (ME) T-cell receptor g alternate reading frame protein (TARP) vaccine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Mar 10, 2022

s Among African American Stage 0-III Prostate Cancer Survivors

Recruiting
  • Cancer Survivor
  • +11 more
  • Accelerometer
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 21, 2022

Prostate Cancer, Cardiovascular Disease Trial in Canada (Nutrition, Exercise, Smoking cessation)

Recruiting
  • Prostate Cancer
  • Cardiovascular Disease
  • Nutrition
  • +4 more
  • Waratah, New South Wales, Australia
  • +37 more
Oct 3, 2022

Metastatic Castration-Resistant Prostate Cancer, Metastatic Breast Cancer, NSCLC Trial in Worldwide (CCS1477, Abiraterone

Recruiting
  • Metastatic Castration-Resistant Prostate Cancer
  • +3 more
  • Boston, Massachusetts
  • +21 more
Jan 10, 2023

Prostate Cancer Trial in France (drug, procedure, radiation)

Active, not recruiting
  • Prostate Cancer
  • Bordeaux, France
  • +16 more
Feb 21, 2022

Prostatic Hyperplasia, Prostate Cancer Trial in Turku (Prostate hyperplasia medication, LhRH-antagonist)

Recruiting
  • Prostatic Hyperplasia
  • Prostate Cancer
  • Turku, Finland
  • +1 more
Aug 17, 2023

Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (TAS3681)

Active, not recruiting
  • Metastatic Castration Resistant Prostate Cancer
  • Sacramento, California
  • +38 more
May 26, 2022

Prostate Cancer Trial in Worldwide (Darolutamide, Placebo oral tablet, Luteinizing Hormone-Releasing Hormone Analog)

Recruiting
  • Prostate Cancer
  • Boston, Massachusetts
  • +74 more
Aug 17, 2022

Prostate Cancer Trial in Canada, United States (70.2 Gy 3D-CRT/IMRT, 79.2 Gy 3D-CRT/IMRT)

Completed
Has Results
  • Prostate Cancer
  • 70.2 Gy 3D-CRT/IMRT
  • 79.2 Gy 3D-CRT/IMRT
  • Long Beach, California
  • +85 more
Dec 27, 2022

Prostate Cancer Trial in Worldwide (Standard of Care)

Recruiting
  • Prostate Cancer
  • Standard of Care
  • Birmingham, Alabama
  • +107 more
Aug 17, 2022

Castration-Resistant Prostate Carcinoma, Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen

Recruiting
  • Castration-Resistant Prostate Carcinoma
  • +7 more
  • Biopsy
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2022

Prostate Cancer Trial in Houston (177Lu rhPSMA-10.1, Degarelix)

Not yet recruiting
  • Prostate Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Sep 27, 2023

Stage IIC Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8, Stage IV Prostate Cancer AJCC v8 Trial in Kansas City

Not yet recruiting
  • Stage IIC Prostate Cancer AJCC v8
  • +2 more
  • Biospecimen Collection
  • +9 more
  • Kansas City, Kansas
    University of Kansas Cancer Center
Nov 3, 2023

Prostate Adenocarcinoma, Prostate Cancer, Prostate Tumor Trial in Leuven, Amsterdam, Nijmegen (Hypo-FLAME 2.0 study)

Active, not recruiting
  • Prostate Adenocarcinoma
  • +2 more
  • Hypo-FLAME 2.0 study
  • Leuven, Belgium
  • +2 more
Jun 7, 2022

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage IIA Prostate Cancer AJCC v8 Trial in Houston

Recruiting
  • Stage I Prostate Cancer AJCC v8
  • +8 more
  • Counseling
  • +4 more
  • Houston, Texas
  • +1 more
Sep 22, 2022

Prostate Cancer Trial in Amiens (MR prostate exam)

Recruiting
  • Prostate Cancer
  • MR prostate exam
  • Amiens, Picardie, France
    Centre Hospitalier Universitaire d'Amiens
Oct 17, 2023

Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

Recruiting
  • Metastatic Prostate Cancer
  • Badalona, Spain
  • +8 more
Jan 18, 2023

Prostate Cancer Trial (Radiotherapy standard, Radiotherapy Hypo-FLAME)

Not yet recruiting
  • Prostate Cancer
  • Radiotherapy standard
  • Radiotherapy Hypo-FLAME
  • (no location specified)
Jan 30, 2023

Prostate Cancer Trial in Worldwide (AZD5305, Darolutamide, No Treatment)

Not yet recruiting
  • Prostate Cancer
  • Melbourne, Australia
  • +7 more
Jul 3, 2023

Prostate Cancer Trial (3D Printed Models (3D printing facilities at GSTT), 3D Virtual Models (Innersight Labs))

Not yet recruiting
  • Prostate Cancer
  • 3D Printed Models (3D printing facilities at GSTT)
  • 3D Virtual Models (Innersight Labs)
  • (no location specified)
Aug 1, 2023

Stage I Prostate Cancer AJCC v8, Stage II Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial (procedure, dietary

Not yet recruiting
  • Stage I Prostate Cancer AJCC v8
  • +3 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Apr 20, 2023

Men With Prostate Cancer Cared for by "Active Surveillance

Not yet recruiting
  • Prostate Cancer
  • Active Surveillance
  • Houston, Texas
    M D Anderson Cancer Center
Apr 24, 2023

Castration-Resistant Prostatic Tumors Trial in Worldwide (Cetrelimab 480 mg, Apalutamide 240 mg)

Completed
  • Castration-Resistant Prostatic Neoplasms
  • Cetrelimab 480 mg
  • Apalutamide 240 mg
  • San Francisco, California
  • +33 more
Feb 24, 2022

Prostatic Tumors Trial in Lyon (HIFU treatment of prostate cancer)

Not yet recruiting
  • Prostatic Neoplasms
  • HIFU treatment of prostate cancer
  • Lyon, France
    Service d'Urologie et Chirurgie de la Transplantation - Hôpital
Jan 27, 2023